These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 32031663

  • 21. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica].
    Yamashita M, Aoki A, Kobayashi H, Wakiya M, Nakatsugawa M.
    Nihon Ronen Igakkai Zasshi; 2023; 60(4):440-447. PubMed ID: 38171762
    [Abstract] [Full Text] [Related]

  • 22. Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.
    Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, Vanderschueren S, Blockmans D.
    Semin Arthritis Rheum; 2024 Oct; 68():152499. PubMed ID: 38968729
    [Abstract] [Full Text] [Related]

  • 23. Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.
    Reilly PA, Maddison PJ.
    Clin Rheumatol; 1987 Jun; 6(2):270-2. PubMed ID: 3621844
    [Abstract] [Full Text] [Related]

  • 24. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C, Boiardi L, Macchioni P, Rossi F, Tartoni P, Casadei Maldini M, Mancini R, Beltrandi E, Portioli I.
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [Abstract] [Full Text] [Related]

  • 25. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
    van Sleen Y, Graver JC, Abdulahad WH, van der Geest KSM, Boots AMH, Sandovici M, Brouwer E.
    Front Immunol; 2019 Aug; 10():1981. PubMed ID: 31507597
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, Stone JR, Stone JH.
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [Abstract] [Full Text] [Related]

  • 28. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [Abstract] [Full Text] [Related]

  • 29. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms.
    Hysa E, Casabella A, Gotelli E, Campitiello R, Schenone C, Genova C, Tanda ET, Sulli A, Smith V, Cimmino MA, Paolino S, Cutolo M.
    Autoimmun Rev; 2024 Sep; 23(7-8):103589. PubMed ID: 39117006
    [Abstract] [Full Text] [Related]

  • 30. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
    Pountain GD, Keogan MT, Brown DL, Hazleman BL.
    Ann Rheum Dis; 1993 Oct; 52(10):730-3. PubMed ID: 8257209
    [Abstract] [Full Text] [Related]

  • 31. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
    Kyle V, Hazleman BL.
    Ann Rheum Dis; 1993 Dec; 52(12):847-50. PubMed ID: 8311533
    [Abstract] [Full Text] [Related]

  • 32. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Narváez J, Bernad B, Díaz Torné C, Momplet JV, Montpel JZ, Nolla JM, Valverde-García J.
    J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
    [Abstract] [Full Text] [Related]

  • 33. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
    Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, Hider S, Roddy E, Mallen C.
    BMC Med; 2018 Jan 10; 16(1):4. PubMed ID: 29316928
    [Abstract] [Full Text] [Related]

  • 34. Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis.
    Borresen SW, Klose M, Baslund B, Rasmussen ÅK, Hilsted L, Friis-Hansen L, Locht H, Hansen A, Hetland ML, Lydolph MC, Feldt-Rasmussen U.
    Eur J Endocrinol; 2017 Oct 10; 177(4):287-295. PubMed ID: 28877961
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH.
    Prim Care; 2018 Jun 10; 45(2):305-323. PubMed ID: 29759126
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.